| Literature DB >> 28040671 |
Valerie Voon1,2, Fabien Droux3, Laurel Morris4, Stephan Chabardes3, Thierry Bougerol3, Olivier David3, Paul Krack3,5, Mircea Polosan3.
Abstract
Why do we make hasty decisions for short-term gain? Rapid decision-making with limited accumulation of evidence and delay discounting are forms of decisional impulsivity. The subthalamic nucleus is implicated in inhibitory function but its role in decisional impulsivity is less well-understood. Here we assess decisional impulsivity in subjects with obsessive compulsive disorder who have undergone deep brain stimulation of the limbic and associative subthalamic nucleus. We show that stimulation of the subthalamic nucleus is causally implicated in increasing decisional impulsivity with less accumulation of evidence during probabilistic uncertainty and in enhancing delay discounting. Subthalamic stimulation shifts evidence accumulation in subjects with obsessive-compulsive disorder towards a functional less cautious style closer to that of healthy controls emphasizing its adaptive nature. Thus, subjects with obsessive compulsive disorder on subthalamic stimulation may be less likely to check for evidence (e.g. checking that the stove is on) with no difference in subjective confidence (or doubt). In a separate study, we replicate in humans (154 healthy controls) using resting state functional connectivity, tracing studies conducted in non-human primates dissociating limbic, associative and motor frontal hyper-direct connectivity with anterior and posterior subregions of the subthalamic nucleus. We show lateralization of functional connectivity of bilateral ventral striatum to right anterior ventromedial subthalamic nucleus consistent with previous observations of lateralization of emotionally evoked activity to right ventral subthalamic nucleus. We use a multi-echo sequence with independent components analysis, which has been shown to have enhanced signal-to-noise ratio, thus optimizing visualization of small subcortical structures. These findings in healthy controls converge with the effective contacts in obsessive compulsive disorder patients localized within the anterior and ventral subthalamic nucleus. We further show that evidence accumulation is associated with anterior associative-limbic subthalamic nucleus and right dorsolateral prefrontal functional connectivity in healthy controls, a region implicated in decision-making under uncertainty. Together, our findings highlight specificity of the anterior associative-limbic subthalamic nucleus in decisional impulsivity. Given increasing interest in the potential for subthalamic stimulation in psychiatric disorders and the neuropsychiatric symptoms of Parkinson's disease, these findings have clinical implications for behavioural symptoms and cognitive effects as a function of localization of subthalamic stimulation.Entities:
Keywords: deep brain stimulation; impulsivity; obsessive-compulsive disorder; subthalamic nucleus; uncertainty
Mesh:
Year: 2016 PMID: 28040671 PMCID: PMC5278307 DOI: 10.1093/brain/aww309
Source DB: PubMed Journal: Brain ISSN: 0006-8950 Impact factor: 13.501
Clinical and demographical characteristics of the OCD patients
| Patient number/age (years)/gender (F/M) | Age at surgery (years) | Duration of disease before surgery (years) | Age at onset of OCD (years) | Duration of DBS (months) | YBOCS before surgery | YBOCS baseline at time of study | Medications at the time of the study |
|---|---|---|---|---|---|---|---|
| 1/46/M | 39 | 18 | 21 | 71 | 37 | 25 | Fluvoxamine 200 mg/day |
| Lorazepam 4 mg/day | |||||||
| 2/49/F | 42 | 25 | 17 | 64 | 30 | 28 | Aripiprazole 30 mg/day |
| Olanzapine 5 mg/day | |||||||
| Escitalopram 20 mg/day | |||||||
| Clomipramine 75 mg/day | |||||||
| 3/39/M | 36 | 17 | 19 | 32 | 32 | 28 | Paroxetine 60 mg/day |
| 4/53/F | 49 | 39 | 10 | 51 | 35 | 29 | Fluoxetine 20 mg/day |
| Clomipramine 25 mg/day | |||||||
| 5/37/M | 34 | 13 | 21 | 22 | 32 | 27 | Clomipramine 150 mg/day |
| Oxazepam 175 mg/day | |||||||
| Alimemazine 50 mg/day | |||||||
| 6/41/F | 38 | 11 | 27 | 35 | 36 | 6 | None |
| 7/43/F | 40 | 15 | 25 | 32 | 36 | 23 | Fluvoxamine 200 mg/day |
| Hydroxyzine 50 mg/day | |||||||
| Clomipramine 25 mg/day | |||||||
| 8/41/F | 37 | 5 | 32 | 44 | 32 | 2 | Venlafaxine 37.5 mg/day |
| Clotiazepam 10 mg/day | |||||||
| 9/30/M | 27 | 10 | 17 | 25 | 38 | 24 | Sertraline 50 mg/day |
| Aripiprazole 20 mg/day | |||||||
| Methylphenidate 60 mg/day | |||||||
| Pitolisant 20 mg/day | |||||||
| 10/56/F | 52 | 25 | 27 | 51 | 40 | 18 | Zopiclone 7.5 mg/day |
| Aripiprazole 2.5 mg/day | |||||||
| Hydroxyzine 100 mg/day | |||||||
| 11/33/F | 33 | 21 | 12 | 5 | 30 | 11 | Venlafaxine 150 mg/day |
| 12/33/F | 33 | 26 | 7 | 25 | 34 | 19 | Fluoxetine 20 mg/day |
| Levothyroxine 125 µg/day |
M = male; F = female.
Figure 1Beads Task and primary outcomes. (A) Beads Task: subjects viewed two jars with opposing ratios of red and blue beads (P = 0.80; P = 0.20). Based on the sequential viewing of beads selected from a jar, participants were asked to make a decision from which jar the beads were selected. The selected beads were shown at the top to control for working memory effects. (B) Evidence accumulated (number of beads prior to decision) in healthy volunteers (HV), OCD subjects on and off DBS targeting the subthalamic nucleus. Error bars represent standard error of the mean. *Related-samples Wilcoxon Signed Rank Test, P < 0.05; **Independent samples Kruskal Wallis test, P < 0.01 with post hoc differences between healthy volunteers and OCD subjects off DBS (P < 0.005).
Figure 3Limbic-associative and motor connectivity dissociating anterior and posterior STN. Resting state functional connectivity of ventral striatal (red) and dorsolateral prefrontal cortex (DLPFC; cyan) seeds to anterior STN and primary motor cortex (blue) seed to posterior STN shown for axial (A), sagittal right (B) and coronal (C) STN slices. Bilateral ventral striatal seeds showed lateralized functional connectivity to right STN. The ventral striatal and dlPFC activations are shown at FWE P < 0.05 and motor activations are shown at FWE P < 0.001 with an STN mask on a standard MNI template. The different thresholds were used for illustration purposes as motor activity at lower threshold otherwise activated the entire STN. A = anterior; P = posterior; V = ventral; D = dorsal.
Figure 4Activity and peak coordinates in the STN of resting state functional connectivity from limbic-associative and motor regions of interest in healthy controls.Top: Ventral striatal (red) and posterior putamen (blue) seed regions of interest were used to compute resting state functional connectivity within STN (small volume corrected for STN FWE P < 0.05). The ventral striatal activations are shown at FWE P < 0.05 and putaminal activation at FWE P < 0.001 with an STN mask on a standard MNI template. The different thresholds were used for illustration purposes as putaminal activity at lower threshold otherwise activated the entire STN. Bottom: The left figures show the seed regions of interest. The 3D plot shows the peak voxels for seed regions of interest correlating with STN. Ventral striatum (VS) had a peak in right anterior STN (y = −11); dlPFC and dACC had peaks bilaterally in anterior STN (y = −11); and SMA and primary motor cortex had peaks bilaterally in posterior STN (y = −14 to −16). The anterior-posterior (A-P) division used to divide anterior associative-limbic and posterior motor STN to examine behavioural correlates were based on the posterior border of dlPFC and ventral striatum at y = −14. Note that the plots for pre-SMA and dACC and for putamen and SMA overlap but for illustration purposes are shown separated by x = 0.5 mm.
Figure 2Evidence accumulation and presurgical severity. (A) Preoperative OCD severity (YBOCS) in OCD subjects on DBS is negatively linearly associated with objective probability at the time of decision. (B) This relationship with objective probability was related to differing responding styles (low or high evidence accumulation, both associated with lower probability). (C) For illustration purposes, the objective probability of the task (i.e. that the correct jar was correct based on the available evidence) is plotted for each trial averaged across the three blocks. Model fits and P-values are reported in the text.
Figure 5Peak coordinates in the STN of resting state functional connectivity from limbic-associative and motor regions of interest in healthy controls. The relationship to optimal DBS contacts from patients with obsessive compulsive disorder in Study 1 are also shown. Resting state functional connectivity for striatal and cortical seed regions of interest and peak connectivity within STN for healthy controls are plotted as per Fig. 4. The top left graph shows these peaks in relation to the averaged coordinates for Contact 1 (C1) and Contact 2 (C2) (actual coordinates in x y z in mm averaged for C1 and C2 across the OCD patients from Study 1; the second and third from the four contacts C0 to C3), contacts from which optimal stimulation targeting obsessive compulsive symptoms was achieved. The bottom right graph shows C1 (small light grey circle) and C2 (small dark grey circle) plotted for each patient.
Figure 7Anterior and posterior STN and decisional impulsivity.Top: The anterior (yellow) and posterior (pink) STN seeds are shown. Bottom: Anterior STN seed-to-whole brain functional connectivity maps were correlated with the primary outcome measure from the Beads Task, the number of beads drawn prior to a decision. The scatter plot shows the parameter estimates (PE) for the correlation in the STN with beads chosen in the right dorsolateral prefrontal cortex (DLPFC). Displayed at P < 0 .005 whole brain uncorrected for illustration on standard MNI template.